Secondary Logo

Journal Logo

Most Popular Articles

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

May, Margaret T.; Gompels, Mark; Delpech, Valerie; More

AIDS. 28(8):1193-1202, May 15, 2014.

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

Gupta, Samir K.; Post, Frank A.; Arribas, José R.; More

AIDS. 33(9):1455-1465, July 15, 2019.

Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial

Kamwesiga, Julius; Mutabazi, Vincent; Kayumba, Josephine; More

AIDS. 29(9):1045-1052, June 1, 2015.

Curable sexually transmitted infections among women with HIV in sub-Saharan Africa

Jarolimova, Jana; Platt, Laura R.; Curtis, Megan R.; More

AIDS. 36(5):697-709, April 1, 2022.

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy

Mills, Anthony; Richmond, Gary J.; Newman, Cheryl; More

AIDS. 36(2):195-203, February 1, 2022.

Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection

Cahn, Pedro; Sierra Madero, Juan; Arribas, José R.; More

AIDS. 36(1):39-48, January 1, 2022.

Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV

Chammartin, Frédérique; Kusejko, Katharina; Pasin, Chloé; More

AIDS. 36(10):1465-1468, August 1, 2022.

Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment

Swindells, Susan; Lutz, Thomas; Van Zyl, Lelanie; More

AIDS. 36(2):185-194, February 1, 2022.

The association of exposure to DREAMS on sexually acquiring or transmitting HIV amongst adolescent girls and young women living in rural South Africa

Mthiyane, Nondumiso; Baisley, Kathy; Chimbindi, Natsayi; More

AIDS. 36(Supplement 1):S39-S49, June 15, 2022.

HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

Suzuki, Kazuo; Levert, Angelique; Yeung, Julie; More

AIDS. 35(13):2095-2103, November 1, 2021.

Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa

Tsondai, Priscilla R.; Braithwaite, Kate; Fatti, Geoffrey; More

AIDS. 34(15):2275-2284, December 1, 2020.

Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between inactivated and mRNA vaccine

Wong, Ngai Sze; Wong, Bonnie C.K.; Chan, Jacky M.C.; More

AIDS. 36(9):1255-1264, July 15, 2022.

DREAMS impact on HIV status knowledge and sexual risk among cohorts of young women in Kenya and South Africa

Floyd, Sian; Mulwa, Sarah; Magut, Faith; More

AIDS. 36(Supplement 1):S61-S73, June 15, 2022.

Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa

Jennings, Lauren; Robbins, Reuben N.; Nguyen, Nadia; More

AIDS. 36(7):933-940, June 1, 2022.

From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017–2020

Patel, Pragna; Sato, Kimi; Bhandari, Neeta; More

AIDS. 36(Supplement 1):S15-S26, June 15, 2022.

The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide

Friedland, Barbara A.; Gottert, Ann; Hows, Julian; More

AIDS. 34:S5-S18, September 1, 2020.

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

Rolle, Charlotte-Paige; Berhe, Mezgebe; Singh, Tulika; More

AIDS. 35(12):1957-1965, October 1, 2021.

Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy

Lachâtre, Marie; Pasquet, Armelle; Ajana, Faïza; More

AIDS. 36(8):1061-1071, July 1, 2022.

Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy

Fleming, Julia; Mathews, W. Christopher; Rutstein, Richard M.; More

AIDS. 33(13):2005-2012, November 1, 2019.

Weight gain stopping/switch rules for antiretroviral clinical trials

Venter, W.D. Francois; Sokhela, Simiso; Calmy, Alexandra; More

AIDS. 35(Supplement 2):S183-S188, December 15, 2021.

Internalized stigma among people living with HIV: assessing the Internalized AIDS-Related Stigma Scale in four countries

Geibel, Scott; Gottert, Ann; Friedland, Barbara A.; More

AIDS. 34:S33-S41, September 1, 2020.

Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country

Stephan, Christoph; Wolf, Timo; Goetsch, Udo; More

AIDS. 22(18):2471-2479, November 30, 2008.

The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India

Kazemian, Pooyan; Ding, Delaney D.; Scott, Justine A.; More

AIDS. 36(9):1223-1232, July 15, 2022.

Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States

Bender Ignacio, Rachel A.; Shapiro, Adrienne E.; Nance, Robin M.; More

AIDS. 36(8):1095-1103, July 1, 2022.

Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis

Molloy, Síle F.; Bradley, John; Karunaharan, Natasha; More

AIDS. 32(15):2259-2261, September 24, 2018.

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

Mohapi, Lerato; Pinedo, Yvett; Osiyemi, Olayemi; More

AIDS. 36(3):373-382, March 1, 2022.

Show: